nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A7—Estradiol—osteoporosis	0.0635	0.119	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0635	0.119	CbGbCtD
Fentanyl—ABCB1—Ethinyl Estradiol—osteoporosis	0.0481	0.0898	CbGbCtD
Fentanyl—CYP3A5—Estradiol—osteoporosis	0.0476	0.0889	CbGbCtD
Fentanyl—CYP3A4—Estropipate—osteoporosis	0.0447	0.0835	CbGbCtD
Fentanyl—CYP3A4—Calcitriol—osteoporosis	0.0447	0.0835	CbGbCtD
Fentanyl—CYP3A4—Ergocalciferol—osteoporosis	0.0358	0.0667	CbGbCtD
Fentanyl—ABCB1—Conjugated Estrogens—osteoporosis	0.0353	0.0659	CbGbCtD
Fentanyl—ABCB1—Estradiol—osteoporosis	0.031	0.0579	CbGbCtD
Fentanyl—CYP3A4—Raloxifene—osteoporosis	0.0298	0.0557	CbGbCtD
Fentanyl—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0288	0.0538	CbGbCtD
Fentanyl—CYP3A4—Cholecalciferol—osteoporosis	0.023	0.043	CbGbCtD
Fentanyl—CYP3A4—Conjugated Estrogens—osteoporosis	0.0212	0.0395	CbGbCtD
Fentanyl—CYP3A4—Estradiol—osteoporosis	0.0186	0.0347	CbGbCtD
Fentanyl—Loperamide—POMC—osteoporosis	0.00153	0.318	CrCbGaD
Fentanyl—Benazepril—MTHFR—osteoporosis	0.00107	0.223	CrCbGaD
Fentanyl—Quinapril—ACE—osteoporosis	0.00101	0.209	CrCbGaD
Fentanyl—Benazepril—ACE—osteoporosis	0.000874	0.181	CrCbGaD
Fentanyl—Methadone—CYP19A1—osteoporosis	0.000333	0.0691	CrCbGaD
Fentanyl—Fatigue—Ethinyl Estradiol—osteoporosis	0.00015	0.000341	CcSEcCtD
Fentanyl—Pruritus—Alendronate—osteoporosis	0.000149	0.00034	CcSEcCtD
Fentanyl—Dyspepsia—Risedronate—osteoporosis	0.000149	0.00034	CcSEcCtD
Fentanyl—Eye disorder—Estradiol—osteoporosis	0.000149	0.000339	CcSEcCtD
Fentanyl—Tinnitus—Estradiol—osteoporosis	0.000149	0.000339	CcSEcCtD
Fentanyl—Constipation—Ethinyl Estradiol—osteoporosis	0.000149	0.000338	CcSEcCtD
Fentanyl—Confusional state—Zoledronate—osteoporosis	0.000148	0.000338	CcSEcCtD
Fentanyl—Hypersensitivity—Calcitriol—osteoporosis	0.000148	0.000338	CcSEcCtD
Fentanyl—Flushing—Estradiol—osteoporosis	0.000148	0.000337	CcSEcCtD
Fentanyl—Cardiac disorder—Estradiol—osteoporosis	0.000148	0.000337	CcSEcCtD
Fentanyl—Arthralgia—Conjugated Estrogens—osteoporosis	0.000148	0.000336	CcSEcCtD
Fentanyl—Myalgia—Conjugated Estrogens—osteoporosis	0.000148	0.000336	CcSEcCtD
Fentanyl—Chest pain—Conjugated Estrogens—osteoporosis	0.000148	0.000336	CcSEcCtD
Fentanyl—Asthenia—Ibandronate—osteoporosis	0.000148	0.000336	CcSEcCtD
Fentanyl—Anxiety—Conjugated Estrogens—osteoporosis	0.000147	0.000335	CcSEcCtD
Fentanyl—Nausea—Etidronic acid—osteoporosis	0.000147	0.000335	CcSEcCtD
Fentanyl—Anaphylactic shock—Zoledronate—osteoporosis	0.000147	0.000335	CcSEcCtD
Fentanyl—Oedema—Zoledronate—osteoporosis	0.000147	0.000335	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000147	0.000334	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000147	0.000334	CcSEcCtD
Fentanyl—Diarrhoea—Estropipate—osteoporosis	0.000147	0.000334	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Risedronate—osteoporosis	0.000146	0.000333	CcSEcCtD
Fentanyl—Infection—Zoledronate—osteoporosis	0.000146	0.000333	CcSEcCtD
Fentanyl—Fatigue—Risedronate—osteoporosis	0.000146	0.000333	CcSEcCtD
Fentanyl—Insomnia—Pamidronate—osteoporosis	0.000146	0.000332	CcSEcCtD
Fentanyl—Pruritus—Ibandronate—osteoporosis	0.000146	0.000331	CcSEcCtD
Fentanyl—Pain—Risedronate—osteoporosis	0.000145	0.00033	CcSEcCtD
Fentanyl—Constipation—Risedronate—osteoporosis	0.000145	0.00033	CcSEcCtD
Fentanyl—Angiopathy—Estradiol—osteoporosis	0.000145	0.00033	CcSEcCtD
Fentanyl—Shock—Zoledronate—osteoporosis	0.000145	0.000329	CcSEcCtD
Fentanyl—Paraesthesia—Pamidronate—osteoporosis	0.000145	0.000329	CcSEcCtD
Fentanyl—Diarrhoea—Alendronate—osteoporosis	0.000145	0.000329	CcSEcCtD
Fentanyl—Asthenia—Calcitriol—osteoporosis	0.000144	0.000329	CcSEcCtD
Fentanyl—Nervous system disorder—Zoledronate—osteoporosis	0.000144	0.000328	CcSEcCtD
Fentanyl—Immune system disorder—Estradiol—osteoporosis	0.000144	0.000328	CcSEcCtD
Fentanyl—Thrombocytopenia—Zoledronate—osteoporosis	0.000144	0.000328	CcSEcCtD
Fentanyl—Mediastinal disorder—Estradiol—osteoporosis	0.000144	0.000327	CcSEcCtD
Fentanyl—Dyspnoea—Pamidronate—osteoporosis	0.000144	0.000327	CcSEcCtD
Fentanyl—Tachycardia—Zoledronate—osteoporosis	0.000144	0.000327	CcSEcCtD
Fentanyl—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000143	0.000326	CcSEcCtD
Fentanyl—Chills—Estradiol—osteoporosis	0.000143	0.000326	CcSEcCtD
Fentanyl—Somnolence—Pamidronate—osteoporosis	0.000143	0.000326	CcSEcCtD
Fentanyl—Skin disorder—Zoledronate—osteoporosis	0.000143	0.000325	CcSEcCtD
Fentanyl—Pruritus—Calcitriol—osteoporosis	0.000142	0.000324	CcSEcCtD
Fentanyl—Hyperhidrosis—Zoledronate—osteoporosis	0.000142	0.000324	CcSEcCtD
Fentanyl—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000142	0.000323	CcSEcCtD
Fentanyl—Diarrhoea—Raloxifene—osteoporosis	0.000142	0.000323	CcSEcCtD
Fentanyl—Dyspepsia—Pamidronate—osteoporosis	0.000142	0.000323	CcSEcCtD
Fentanyl—Dizziness—Estropipate—osteoporosis	0.000142	0.000323	CcSEcCtD
Fentanyl—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000142	0.000322	CcSEcCtD
Fentanyl—Oedema—Conjugated Estrogens—osteoporosis	0.000142	0.000322	CcSEcCtD
Fentanyl—Alopecia—Estradiol—osteoporosis	0.000141	0.000321	CcSEcCtD
Fentanyl—Infection—Conjugated Estrogens—osteoporosis	0.000141	0.00032	CcSEcCtD
Fentanyl—Diarrhoea—Ibandronate—osteoporosis	0.000141	0.00032	CcSEcCtD
Fentanyl—Anorexia—Zoledronate—osteoporosis	0.00014	0.000319	CcSEcCtD
Fentanyl—Decreased appetite—Pamidronate—osteoporosis	0.00014	0.000319	CcSEcCtD
Fentanyl—Mental disorder—Estradiol—osteoporosis	0.00014	0.000318	CcSEcCtD
Fentanyl—Dizziness—Alendronate—osteoporosis	0.00014	0.000318	CcSEcCtD
Fentanyl—Shock—Conjugated Estrogens—osteoporosis	0.000139	0.000317	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000139	0.000317	CcSEcCtD
Fentanyl—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000139	0.000316	CcSEcCtD
Fentanyl—Malnutrition—Estradiol—osteoporosis	0.000139	0.000316	CcSEcCtD
Fentanyl—Erythema—Estradiol—osteoporosis	0.000139	0.000316	CcSEcCtD
Fentanyl—Fatigue—Pamidronate—osteoporosis	0.000139	0.000316	CcSEcCtD
Fentanyl—Gastrointestinal pain—Risedronate—osteoporosis	0.000139	0.000315	CcSEcCtD
Fentanyl—Tachycardia—Conjugated Estrogens—osteoporosis	0.000138	0.000315	CcSEcCtD
Fentanyl—Urticaria—Ethinyl Estradiol—osteoporosis	0.000138	0.000314	CcSEcCtD
Fentanyl—Constipation—Pamidronate—osteoporosis	0.000138	0.000314	CcSEcCtD
Fentanyl—Pain—Pamidronate—osteoporosis	0.000138	0.000314	CcSEcCtD
Fentanyl—Diarrhoea—Calcitriol—osteoporosis	0.000138	0.000313	CcSEcCtD
Fentanyl—Skin disorder—Conjugated Estrogens—osteoporosis	0.000138	0.000313	CcSEcCtD
Fentanyl—Hypotension—Zoledronate—osteoporosis	0.000138	0.000313	CcSEcCtD
Fentanyl—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000137	0.000313	CcSEcCtD
Fentanyl—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000137	0.000313	CcSEcCtD
Fentanyl—Dizziness—Raloxifene—osteoporosis	0.000137	0.000313	CcSEcCtD
Fentanyl—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000137	0.000312	CcSEcCtD
Fentanyl—Flatulence—Estradiol—osteoporosis	0.000137	0.000312	CcSEcCtD
Fentanyl—Tension—Estradiol—osteoporosis	0.000136	0.00031	CcSEcCtD
Fentanyl—Vomiting—Estropipate—osteoporosis	0.000136	0.00031	CcSEcCtD
Fentanyl—Dysgeusia—Estradiol—osteoporosis	0.000136	0.00031	CcSEcCtD
Fentanyl—Dizziness—Ibandronate—osteoporosis	0.000136	0.000309	CcSEcCtD
Fentanyl—Rash—Estropipate—osteoporosis	0.000135	0.000308	CcSEcCtD
Fentanyl—Dermatitis—Estropipate—osteoporosis	0.000135	0.000307	CcSEcCtD
Fentanyl—Anorexia—Conjugated Estrogens—osteoporosis	0.000135	0.000307	CcSEcCtD
Fentanyl—Nervousness—Estradiol—osteoporosis	0.000135	0.000307	CcSEcCtD
Fentanyl—Urticaria—Risedronate—osteoporosis	0.000135	0.000306	CcSEcCtD
Fentanyl—Back pain—Estradiol—osteoporosis	0.000134	0.000306	CcSEcCtD
Fentanyl—Headache—Estropipate—osteoporosis	0.000134	0.000306	CcSEcCtD
Fentanyl—Vomiting—Alendronate—osteoporosis	0.000134	0.000306	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000134	0.000305	CcSEcCtD
Fentanyl—Abdominal pain—Risedronate—osteoporosis	0.000134	0.000305	CcSEcCtD
Fentanyl—Body temperature increased—Risedronate—osteoporosis	0.000134	0.000305	CcSEcCtD
Fentanyl—Muscle spasms—Estradiol—osteoporosis	0.000134	0.000304	CcSEcCtD
Fentanyl—Rash—Alendronate—osteoporosis	0.000133	0.000303	CcSEcCtD
Fentanyl—Insomnia—Zoledronate—osteoporosis	0.000133	0.000303	CcSEcCtD
Fentanyl—Dermatitis—Alendronate—osteoporosis	0.000133	0.000303	CcSEcCtD
Fentanyl—Feeling abnormal—Pamidronate—osteoporosis	0.000133	0.000302	CcSEcCtD
Fentanyl—Hypotension—Conjugated Estrogens—osteoporosis	0.000132	0.000301	CcSEcCtD
Fentanyl—Headache—Alendronate—osteoporosis	0.000132	0.000301	CcSEcCtD
Fentanyl—Paraesthesia—Zoledronate—osteoporosis	0.000132	0.000301	CcSEcCtD
Fentanyl—Vomiting—Raloxifene—osteoporosis	0.000132	0.000301	CcSEcCtD
Fentanyl—Gastrointestinal pain—Pamidronate—osteoporosis	0.000132	0.0003	CcSEcCtD
Fentanyl—Dyspnoea—Zoledronate—osteoporosis	0.000131	0.000299	CcSEcCtD
Fentanyl—Rash—Raloxifene—osteoporosis	0.000131	0.000298	CcSEcCtD
Fentanyl—Dermatitis—Raloxifene—osteoporosis	0.000131	0.000298	CcSEcCtD
Fentanyl—Somnolence—Zoledronate—osteoporosis	0.000131	0.000298	CcSEcCtD
Fentanyl—Vomiting—Ibandronate—osteoporosis	0.000131	0.000298	CcSEcCtD
Fentanyl—Tremor—Estradiol—osteoporosis	0.00013	0.000296	CcSEcCtD
Fentanyl—Headache—Raloxifene—osteoporosis	0.00013	0.000296	CcSEcCtD
Fentanyl—Rash—Ibandronate—osteoporosis	0.00013	0.000295	CcSEcCtD
Fentanyl—Dermatitis—Ibandronate—osteoporosis	0.00013	0.000295	CcSEcCtD
Fentanyl—Dyspepsia—Zoledronate—osteoporosis	0.00013	0.000295	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000129	0.000294	CcSEcCtD
Fentanyl—Ill-defined disorder—Estradiol—osteoporosis	0.000129	0.000293	CcSEcCtD
Fentanyl—Headache—Ibandronate—osteoporosis	0.000129	0.000293	CcSEcCtD
Fentanyl—Insomnia—Conjugated Estrogens—osteoporosis	0.000128	0.000292	CcSEcCtD
Fentanyl—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000128	0.000291	CcSEcCtD
Fentanyl—Vomiting—Calcitriol—osteoporosis	0.000128	0.000291	CcSEcCtD
Fentanyl—Decreased appetite—Zoledronate—osteoporosis	0.000128	0.000291	CcSEcCtD
Fentanyl—Agitation—Estradiol—osteoporosis	0.000128	0.000291	CcSEcCtD
Fentanyl—Nausea—Estropipate—osteoporosis	0.000127	0.00029	CcSEcCtD
Fentanyl—Body temperature increased—Pamidronate—osteoporosis	0.000127	0.00029	CcSEcCtD
Fentanyl—Abdominal pain—Pamidronate—osteoporosis	0.000127	0.00029	CcSEcCtD
Fentanyl—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000127	0.00029	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000127	0.000289	CcSEcCtD
Fentanyl—Rash—Calcitriol—osteoporosis	0.000127	0.000289	CcSEcCtD
Fentanyl—Fatigue—Zoledronate—osteoporosis	0.000127	0.000289	CcSEcCtD
Fentanyl—Dermatitis—Calcitriol—osteoporosis	0.000127	0.000289	CcSEcCtD
Fentanyl—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000126	0.000287	CcSEcCtD
Fentanyl—Headache—Calcitriol—osteoporosis	0.000126	0.000287	CcSEcCtD
Fentanyl—Somnolence—Conjugated Estrogens—osteoporosis	0.000126	0.000287	CcSEcCtD
Fentanyl—Constipation—Zoledronate—osteoporosis	0.000126	0.000286	CcSEcCtD
Fentanyl—Pain—Zoledronate—osteoporosis	0.000126	0.000286	CcSEcCtD
Fentanyl—Nausea—Alendronate—osteoporosis	0.000125	0.000286	CcSEcCtD
Fentanyl—Malaise—Estradiol—osteoporosis	0.000125	0.000285	CcSEcCtD
Fentanyl—Hypersensitivity—Risedronate—osteoporosis	0.000125	0.000284	CcSEcCtD
Fentanyl—Vertigo—Estradiol—osteoporosis	0.000125	0.000284	CcSEcCtD
Fentanyl—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000125	0.000284	CcSEcCtD
Fentanyl—Asthenia—Ethinyl Estradiol—osteoporosis	0.000125	0.000284	CcSEcCtD
Fentanyl—Syncope—Estradiol—osteoporosis	0.000125	0.000284	CcSEcCtD
Fentanyl—Nausea—Raloxifene—osteoporosis	0.000123	0.000281	CcSEcCtD
Fentanyl—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000123	0.00028	CcSEcCtD
Fentanyl—Pruritus—Ethinyl Estradiol—osteoporosis	0.000123	0.00028	CcSEcCtD
Fentanyl—Palpitations—Estradiol—osteoporosis	0.000123	0.000279	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000122	0.000278	CcSEcCtD
Fentanyl—Fatigue—Conjugated Estrogens—osteoporosis	0.000122	0.000278	CcSEcCtD
Fentanyl—Nausea—Ibandronate—osteoporosis	0.000122	0.000278	CcSEcCtD
Fentanyl—Loss of consciousness—Estradiol—osteoporosis	0.000122	0.000278	CcSEcCtD
Fentanyl—Asthenia—Risedronate—osteoporosis	0.000122	0.000277	CcSEcCtD
Fentanyl—Feeling abnormal—Zoledronate—osteoporosis	0.000121	0.000276	CcSEcCtD
Fentanyl—Cough—Estradiol—osteoporosis	0.000121	0.000276	CcSEcCtD
Fentanyl—Constipation—Conjugated Estrogens—osteoporosis	0.000121	0.000276	CcSEcCtD
Fentanyl—Pain—Conjugated Estrogens—osteoporosis	0.000121	0.000276	CcSEcCtD
Fentanyl—Gastrointestinal pain—Zoledronate—osteoporosis	0.00012	0.000274	CcSEcCtD
Fentanyl—Hypertension—Estradiol—osteoporosis	0.00012	0.000273	CcSEcCtD
Fentanyl—Pruritus—Risedronate—osteoporosis	0.00012	0.000273	CcSEcCtD
Fentanyl—Nausea—Calcitriol—osteoporosis	0.00012	0.000272	CcSEcCtD
Fentanyl—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000119	0.000271	CcSEcCtD
Fentanyl—Hypersensitivity—Pamidronate—osteoporosis	0.000119	0.00027	CcSEcCtD
Fentanyl—Chest pain—Estradiol—osteoporosis	0.000118	0.000269	CcSEcCtD
Fentanyl—Arthralgia—Estradiol—osteoporosis	0.000118	0.000269	CcSEcCtD
Fentanyl—Myalgia—Estradiol—osteoporosis	0.000118	0.000269	CcSEcCtD
Fentanyl—Anxiety—Estradiol—osteoporosis	0.000118	0.000268	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000117	0.000267	CcSEcCtD
Fentanyl—Urticaria—Zoledronate—osteoporosis	0.000117	0.000266	CcSEcCtD
Fentanyl—Discomfort—Estradiol—osteoporosis	0.000117	0.000266	CcSEcCtD
Fentanyl—Body temperature increased—Zoledronate—osteoporosis	0.000116	0.000265	CcSEcCtD
Fentanyl—Abdominal pain—Zoledronate—osteoporosis	0.000116	0.000265	CcSEcCtD
Fentanyl—Diarrhoea—Risedronate—osteoporosis	0.000116	0.000264	CcSEcCtD
Fentanyl—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000116	0.000264	CcSEcCtD
Fentanyl—Dry mouth—Estradiol—osteoporosis	0.000116	0.000263	CcSEcCtD
Fentanyl—Asthenia—Pamidronate—osteoporosis	0.000116	0.000263	CcSEcCtD
Fentanyl—Dizziness—Ethinyl Estradiol—osteoporosis	0.000115	0.000262	CcSEcCtD
Fentanyl—Confusional state—Estradiol—osteoporosis	0.000114	0.00026	CcSEcCtD
Fentanyl—Pruritus—Pamidronate—osteoporosis	0.000114	0.000259	CcSEcCtD
Fentanyl—Anaphylactic shock—Estradiol—osteoporosis	0.000113	0.000258	CcSEcCtD
Fentanyl—Oedema—Estradiol—osteoporosis	0.000113	0.000258	CcSEcCtD
Fentanyl—Infection—Estradiol—osteoporosis	0.000113	0.000256	CcSEcCtD
Fentanyl—Urticaria—Conjugated Estrogens—osteoporosis	0.000113	0.000256	CcSEcCtD
Fentanyl—Dizziness—Risedronate—osteoporosis	0.000112	0.000255	CcSEcCtD
Fentanyl—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000112	0.000255	CcSEcCtD
Fentanyl—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000112	0.000255	CcSEcCtD
Fentanyl—Shock—Estradiol—osteoporosis	0.000112	0.000254	CcSEcCtD
Fentanyl—Nervous system disorder—Estradiol—osteoporosis	0.000111	0.000253	CcSEcCtD
Fentanyl—Tachycardia—Estradiol—osteoporosis	0.000111	0.000252	CcSEcCtD
Fentanyl—Vomiting—Ethinyl Estradiol—osteoporosis	0.000111	0.000252	CcSEcCtD
Fentanyl—Diarrhoea—Pamidronate—osteoporosis	0.00011	0.000251	CcSEcCtD
Fentanyl—Skin disorder—Estradiol—osteoporosis	0.00011	0.000251	CcSEcCtD
Fentanyl—Hyperhidrosis—Estradiol—osteoporosis	0.00011	0.000249	CcSEcCtD
Fentanyl—Rash—Ethinyl Estradiol—osteoporosis	0.00011	0.000249	CcSEcCtD
Fentanyl—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00011	0.000249	CcSEcCtD
Fentanyl—Headache—Ethinyl Estradiol—osteoporosis	0.000109	0.000248	CcSEcCtD
Fentanyl—Hypersensitivity—Zoledronate—osteoporosis	0.000108	0.000247	CcSEcCtD
Fentanyl—Vomiting—Risedronate—osteoporosis	0.000108	0.000245	CcSEcCtD
Fentanyl—Rash—Risedronate—osteoporosis	0.000107	0.000243	CcSEcCtD
Fentanyl—Dermatitis—Risedronate—osteoporosis	0.000107	0.000243	CcSEcCtD
Fentanyl—Dizziness—Pamidronate—osteoporosis	0.000107	0.000242	CcSEcCtD
Fentanyl—Headache—Risedronate—osteoporosis	0.000106	0.000242	CcSEcCtD
Fentanyl—Asthenia—Zoledronate—osteoporosis	0.000106	0.00024	CcSEcCtD
Fentanyl—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000104	0.000238	CcSEcCtD
Fentanyl—Pruritus—Zoledronate—osteoporosis	0.000104	0.000237	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000103	0.000235	CcSEcCtD
Fentanyl—Nausea—Ethinyl Estradiol—osteoporosis	0.000103	0.000235	CcSEcCtD
Fentanyl—Insomnia—Estradiol—osteoporosis	0.000103	0.000233	CcSEcCtD
Fentanyl—Vomiting—Pamidronate—osteoporosis	0.000102	0.000233	CcSEcCtD
Fentanyl—Paraesthesia—Estradiol—osteoporosis	0.000102	0.000232	CcSEcCtD
Fentanyl—Asthenia—Conjugated Estrogens—osteoporosis	0.000102	0.000231	CcSEcCtD
Fentanyl—Rash—Pamidronate—osteoporosis	0.000102	0.000231	CcSEcCtD
Fentanyl—Dermatitis—Pamidronate—osteoporosis	0.000101	0.000231	CcSEcCtD
Fentanyl—Dyspnoea—Estradiol—osteoporosis	0.000101	0.00023	CcSEcCtD
Fentanyl—Headache—Pamidronate—osteoporosis	0.000101	0.00023	CcSEcCtD
Fentanyl—Somnolence—Estradiol—osteoporosis	0.000101	0.000229	CcSEcCtD
Fentanyl—Diarrhoea—Zoledronate—osteoporosis	0.000101	0.000229	CcSEcCtD
Fentanyl—Nausea—Risedronate—osteoporosis	0.000101	0.000229	CcSEcCtD
Fentanyl—Pruritus—Conjugated Estrogens—osteoporosis	0.0001	0.000228	CcSEcCtD
Fentanyl—Dyspepsia—Estradiol—osteoporosis	9.98e-05	0.000227	CcSEcCtD
Fentanyl—Decreased appetite—Estradiol—osteoporosis	9.86e-05	0.000224	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Estradiol—osteoporosis	9.79e-05	0.000223	CcSEcCtD
Fentanyl—Fatigue—Estradiol—osteoporosis	9.78e-05	0.000223	CcSEcCtD
Fentanyl—Dizziness—Zoledronate—osteoporosis	9.73e-05	0.000221	CcSEcCtD
Fentanyl—Pain—Estradiol—osteoporosis	9.7e-05	0.000221	CcSEcCtD
Fentanyl—Constipation—Estradiol—osteoporosis	9.7e-05	0.000221	CcSEcCtD
Fentanyl—Diarrhoea—Conjugated Estrogens—osteoporosis	9.7e-05	0.000221	CcSEcCtD
Fentanyl—Nausea—Pamidronate—osteoporosis	9.57e-05	0.000218	CcSEcCtD
Fentanyl—Dizziness—Conjugated Estrogens—osteoporosis	9.37e-05	0.000213	CcSEcCtD
Fentanyl—Vomiting—Zoledronate—osteoporosis	9.36e-05	0.000213	CcSEcCtD
Fentanyl—Feeling abnormal—Estradiol—osteoporosis	9.35e-05	0.000213	CcSEcCtD
Fentanyl—Rash—Zoledronate—osteoporosis	9.28e-05	0.000211	CcSEcCtD
Fentanyl—Gastrointestinal pain—Estradiol—osteoporosis	9.27e-05	0.000211	CcSEcCtD
Fentanyl—Dermatitis—Zoledronate—osteoporosis	9.27e-05	0.000211	CcSEcCtD
Fentanyl—Headache—Zoledronate—osteoporosis	9.22e-05	0.00021	CcSEcCtD
Fentanyl—Vomiting—Conjugated Estrogens—osteoporosis	9.01e-05	0.000205	CcSEcCtD
Fentanyl—Urticaria—Estradiol—osteoporosis	9.01e-05	0.000205	CcSEcCtD
Fentanyl—Body temperature increased—Estradiol—osteoporosis	8.97e-05	0.000204	CcSEcCtD
Fentanyl—Abdominal pain—Estradiol—osteoporosis	8.97e-05	0.000204	CcSEcCtD
Fentanyl—Rash—Conjugated Estrogens—osteoporosis	8.93e-05	0.000203	CcSEcCtD
Fentanyl—Dermatitis—Conjugated Estrogens—osteoporosis	8.93e-05	0.000203	CcSEcCtD
Fentanyl—Headache—Conjugated Estrogens—osteoporosis	8.88e-05	0.000202	CcSEcCtD
Fentanyl—Nausea—Zoledronate—osteoporosis	8.74e-05	0.000199	CcSEcCtD
Fentanyl—Nausea—Conjugated Estrogens—osteoporosis	8.42e-05	0.000192	CcSEcCtD
Fentanyl—Hypersensitivity—Estradiol—osteoporosis	8.36e-05	0.00019	CcSEcCtD
Fentanyl—Asthenia—Estradiol—osteoporosis	8.14e-05	0.000185	CcSEcCtD
Fentanyl—Pruritus—Estradiol—osteoporosis	8.02e-05	0.000183	CcSEcCtD
Fentanyl—Diarrhoea—Estradiol—osteoporosis	7.76e-05	0.000177	CcSEcCtD
Fentanyl—Dizziness—Estradiol—osteoporosis	7.5e-05	0.000171	CcSEcCtD
Fentanyl—Vomiting—Estradiol—osteoporosis	7.21e-05	0.000164	CcSEcCtD
Fentanyl—Rash—Estradiol—osteoporosis	7.15e-05	0.000163	CcSEcCtD
Fentanyl—Dermatitis—Estradiol—osteoporosis	7.14e-05	0.000163	CcSEcCtD
Fentanyl—Headache—Estradiol—osteoporosis	7.11e-05	0.000162	CcSEcCtD
Fentanyl—Nausea—Estradiol—osteoporosis	6.74e-05	0.000153	CcSEcCtD
Fentanyl—OPRM1—G alpha (i) signalling events—POMC—osteoporosis	4.15e-05	0.00207	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GPD2—osteoporosis	4.09e-05	0.00204	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PGLS—osteoporosis	4.09e-05	0.00204	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MGLL—osteoporosis	4.07e-05	0.00203	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PTH—osteoporosis	3.99e-05	0.00199	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LRP5—osteoporosis	3.97e-05	0.00198	CbGpPWpGaD
Fentanyl—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	3.94e-05	0.00197	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.9e-05	0.00195	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CNR2—osteoporosis	3.89e-05	0.00194	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—IL6—osteoporosis	3.88e-05	0.00194	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LRP6—osteoporosis	3.8e-05	0.00189	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CALCR—osteoporosis	3.8e-05	0.00189	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTH1R—osteoporosis	3.8e-05	0.00189	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PTHLH—osteoporosis	3.77e-05	0.00188	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ATIC—osteoporosis	3.74e-05	0.00187	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PNP—osteoporosis	3.74e-05	0.00187	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PTH—osteoporosis	3.72e-05	0.00185	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—WNT1—osteoporosis	3.66e-05	0.00182	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CALCA—osteoporosis	3.66e-05	0.00182	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PTHLH—osteoporosis	3.64e-05	0.00182	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CNR2—osteoporosis	3.62e-05	0.00181	CbGpPWpGaD
Fentanyl—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.57e-05	0.00178	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MGLL—osteoporosis	3.57e-05	0.00178	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LRP5—osteoporosis	3.48e-05	0.00174	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL1B—osteoporosis	3.45e-05	0.00172	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—POMC—osteoporosis	3.39e-05	0.00169	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PTH—osteoporosis	3.38e-05	0.00168	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LRP6—osteoporosis	3.33e-05	0.00166	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CALCA—osteoporosis	3.32e-05	0.00166	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PTHLH—osteoporosis	3.31e-05	0.00165	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—POMC—osteoporosis	3.31e-05	0.00165	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.3e-05	0.00165	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.3e-05	0.00164	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CNR2—osteoporosis	3.29e-05	0.00164	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CALCA—osteoporosis	3.21e-05	0.0016	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TLN1—osteoporosis	3.21e-05	0.0016	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—OXCT1—osteoporosis	3.18e-05	0.00159	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CA2—osteoporosis	3.18e-05	0.00159	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PKM—osteoporosis	3.12e-05	0.00156	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—FDPS—osteoporosis	3.12e-05	0.00156	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MGLL—osteoporosis	3.1e-05	0.00155	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—WNT1—osteoporosis	3.09e-05	0.00154	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PTHLH—osteoporosis	3.08e-05	0.00154	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MGLL—osteoporosis	3.02e-05	0.0015	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—POMC—osteoporosis	2.97e-05	0.00148	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PGLS—osteoporosis	2.96e-05	0.00148	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPD2—osteoporosis	2.96e-05	0.00148	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LRP5—osteoporosis	2.94e-05	0.00147	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CALCA—osteoporosis	2.91e-05	0.00145	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.9e-05	0.00144	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LRP6—osteoporosis	2.81e-05	0.0014	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TLN1—osteoporosis	2.81e-05	0.0014	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PTHLH—osteoporosis	2.8e-05	0.00139	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—P4HB—osteoporosis	2.77e-05	0.00138	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CALCA—osteoporosis	2.71e-05	0.00135	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PNP—osteoporosis	2.71e-05	0.00135	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ATIC—osteoporosis	2.71e-05	0.00135	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTH—osteoporosis	2.69e-05	0.00134	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TGFB1—osteoporosis	2.68e-05	0.00134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAP1A—osteoporosis	2.64e-05	0.00132	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—IDH2—osteoporosis	2.64e-05	0.00132	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CNR2—osteoporosis	2.62e-05	0.00131	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADCY5—osteoporosis	2.6e-05	0.0013	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NFATC1—osteoporosis	2.58e-05	0.00129	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.56e-05	0.00128	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—DKK1—osteoporosis	2.56e-05	0.00128	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	2.55e-05	0.00127	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.52e-05	0.00126	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—POMC—osteoporosis	2.51e-05	0.00125	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TNF—osteoporosis	2.51e-05	0.00125	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP27A1—osteoporosis	2.48e-05	0.00124	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—WNT1—osteoporosis	2.47e-05	0.00123	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CALCA—osteoporosis	2.46e-05	0.00123	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—P4HB—osteoporosis	2.43e-05	0.00121	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ACP5—osteoporosis	2.41e-05	0.0012	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGA—osteoporosis	2.4e-05	0.0012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TLN1—osteoporosis	2.38e-05	0.00119	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADCY5—osteoporosis	2.36e-05	0.00118	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTH—osteoporosis	2.36e-05	0.00118	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PKM—osteoporosis	2.35e-05	0.00117	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—FDPS—osteoporosis	2.35e-05	0.00117	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RAP1A—osteoporosis	2.32e-05	0.00116	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—OXCT1—osteoporosis	2.3e-05	0.00115	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CA2—osteoporosis	2.3e-05	0.00115	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CNR2—osteoporosis	2.3e-05	0.00115	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADCY5—osteoporosis	2.28e-05	0.00114	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFATC1—osteoporosis	2.26e-05	0.00113	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—DKK1—osteoporosis	2.24e-05	0.00112	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TPI1—osteoporosis	2.24e-05	0.00112	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MGLL—osteoporosis	2.24e-05	0.00112	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPD2—osteoporosis	2.23e-05	0.00111	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PGLS—osteoporosis	2.23e-05	0.00111	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTHLH—osteoporosis	2.23e-05	0.00111	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BMP2—osteoporosis	2.23e-05	0.00111	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.21e-05	0.0011	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGB—osteoporosis	2.18e-05	0.00109	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—WNT1—osteoporosis	2.16e-05	0.00108	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—P4HB—osteoporosis	2.11e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PSMA2—osteoporosis	2.11e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PSMA5—osteoporosis	2.11e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGA—osteoporosis	2.1e-05	0.00105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADCY5—osteoporosis	2.07e-05	0.00103	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GAPDH—osteoporosis	2.07e-05	0.00103	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—P4HB—osteoporosis	2.05e-05	0.00102	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PNP—osteoporosis	2.04e-05	0.00102	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ATIC—osteoporosis	2.04e-05	0.00102	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—RAP1A—osteoporosis	2.02e-05	0.00101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTH—osteoporosis	1.99e-05	0.000994	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CALCA—osteoporosis	1.96e-05	0.000979	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAP1A—osteoporosis	1.96e-05	0.000977	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BMP2—osteoporosis	1.95e-05	0.000975	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTHLH—osteoporosis	1.95e-05	0.000975	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CNR2—osteoporosis	1.94e-05	0.000969	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	1.93e-05	0.000962	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—POMC—osteoporosis	1.91e-05	0.000955	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGB—osteoporosis	1.91e-05	0.000954	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFATC1—osteoporosis	1.91e-05	0.000953	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—IDH2—osteoporosis	1.91e-05	0.000951	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—DKK1—osteoporosis	1.9e-05	0.000946	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PSMA2—osteoporosis	1.85e-05	0.000921	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PSMA5—osteoporosis	1.85e-05	0.000921	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—WNT1—osteoporosis	1.83e-05	0.000911	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.79e-05	0.000894	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KL—osteoporosis	1.78e-05	0.000889	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGA—osteoporosis	1.78e-05	0.000886	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	1.75e-05	0.000873	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ACP5—osteoporosis	1.74e-05	0.000869	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—POMC—osteoporosis	1.74e-05	0.000867	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CA2—osteoporosis	1.74e-05	0.000866	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—OXCT1—osteoporosis	1.74e-05	0.000866	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CALCA—osteoporosis	1.72e-05	0.000858	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6R—osteoporosis	1.7e-05	0.000846	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MGLL—osteoporosis	1.69e-05	0.000844	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—POMC—osteoporosis	1.68e-05	0.000837	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTHLH—osteoporosis	1.65e-05	0.000824	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BMP2—osteoporosis	1.65e-05	0.000824	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ENO1—osteoporosis	1.63e-05	0.000812	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TPI1—osteoporosis	1.62e-05	0.000808	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGB—osteoporosis	1.62e-05	0.000806	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PSMA2—osteoporosis	1.61e-05	0.000801	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PSMA5—osteoporosis	1.61e-05	0.000801	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KL—osteoporosis	1.56e-05	0.000779	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PSMA2—osteoporosis	1.56e-05	0.000778	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PSMA5—osteoporosis	1.56e-05	0.000778	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—POMC—osteoporosis	1.54e-05	0.000767	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—POMC—osteoporosis	1.52e-05	0.00076	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—P4HB—osteoporosis	1.52e-05	0.00076	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GAPDH—osteoporosis	1.5e-05	0.000746	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6R—osteoporosis	1.49e-05	0.000741	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—RAP1A—osteoporosis	1.46e-05	0.000726	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CALCA—osteoporosis	1.45e-05	0.000725	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FDPS—osteoporosis	1.45e-05	0.000723	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PKM—osteoporosis	1.45e-05	0.000723	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—IDH2—osteoporosis	1.44e-05	0.000717	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—POMC—osteoporosis	1.42e-05	0.000707	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADCY5—osteoporosis	1.4e-05	0.000696	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPD2—osteoporosis	1.38e-05	0.000686	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PGLS—osteoporosis	1.38e-05	0.000686	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP27A1—osteoporosis	1.35e-05	0.000674	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SPP1—osteoporosis	1.35e-05	0.000674	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.33e-05	0.000662	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.32e-05	0.00066	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KL—osteoporosis	1.32e-05	0.000659	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ACP5—osteoporosis	1.32e-05	0.000656	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.3e-05	0.000649	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—POMC—osteoporosis	1.29e-05	0.000642	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ATIC—osteoporosis	1.26e-05	0.000627	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PNP—osteoporosis	1.26e-05	0.000627	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6R—osteoporosis	1.26e-05	0.000627	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.24e-05	0.000618	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.24e-05	0.000616	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADCY5—osteoporosis	1.22e-05	0.00061	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TPI1—osteoporosis	1.22e-05	0.00061	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IRS2—osteoporosis	1.22e-05	0.000609	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LEP—osteoporosis	1.2e-05	0.000596	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SPP1—osteoporosis	1.18e-05	0.000591	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ENO1—osteoporosis	1.18e-05	0.000587	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PSMA2—osteoporosis	1.16e-05	0.000579	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PSMA5—osteoporosis	1.16e-05	0.000579	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—P4HB—osteoporosis	1.15e-05	0.000573	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ESR1—osteoporosis	1.14e-05	0.000569	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GAPDH—osteoporosis	1.13e-05	0.000563	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—RAP1A—osteoporosis	1.1e-05	0.000548	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IRS2—osteoporosis	1.07e-05	0.000534	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CA2—osteoporosis	1.07e-05	0.000533	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—OXCT1—osteoporosis	1.07e-05	0.000533	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IRS1—osteoporosis	1.07e-05	0.000532	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ADCY5—osteoporosis	1.06e-05	0.000531	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GPX1—osteoporosis	1.06e-05	0.000529	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LEP—osteoporosis	1.05e-05	0.000523	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MGLL—osteoporosis	1.04e-05	0.00052	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADCY5—osteoporosis	1.03e-05	0.000516	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—POMC—osteoporosis	1.03e-05	0.000512	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6R—osteoporosis	1e-05	0.0005	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SPP1—osteoporosis	1e-05	0.000499	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ESR1—osteoporosis	1e-05	0.000499	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—osteoporosis	9.88e-06	0.000493	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—osteoporosis	9.79e-06	0.000488	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP19A1—osteoporosis	9.41e-06	0.000469	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IRS1—osteoporosis	9.35e-06	0.000466	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS2—osteoporosis	9.05e-06	0.000451	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—osteoporosis	9e-06	0.000449	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ENO1—osteoporosis	8.89e-06	0.000443	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—IDH2—osteoporosis	8.86e-06	0.000442	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—osteoporosis	8.86e-06	0.000442	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6R—osteoporosis	8.78e-06	0.000438	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMA5—osteoporosis	8.76e-06	0.000437	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMA2—osteoporosis	8.76e-06	0.000437	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—osteoporosis	8.66e-06	0.000432	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—osteoporosis	8.46e-06	0.000422	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.33e-06	0.000416	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACP5—osteoporosis	8.11e-06	0.000404	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS1—osteoporosis	7.9e-06	0.000394	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—osteoporosis	7.83e-06	0.00039	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ADCY5—osteoporosis	7.69e-06	0.000384	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPX1—osteoporosis	7.67e-06	0.000382	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—osteoporosis	7.61e-06	0.000379	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—osteoporosis	7.55e-06	0.000377	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TPI1—osteoporosis	7.54e-06	0.000376	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6R—osteoporosis	7.42e-06	0.00037	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—osteoporosis	7.32e-06	0.000365	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP19A1—osteoporosis	7.1e-06	0.000354	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—P4HB—osteoporosis	7.08e-06	0.000353	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—osteoporosis	7.07e-06	0.000353	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GAPDH—osteoporosis	6.95e-06	0.000347	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—RAP1A—osteoporosis	6.77e-06	0.000338	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—osteoporosis	6.62e-06	0.00033	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—osteoporosis	5.94e-06	0.000296	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—osteoporosis	5.92e-06	0.000295	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADCY5—osteoporosis	5.8e-06	0.000289	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPX1—osteoporosis	5.78e-06	0.000288	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—osteoporosis	5.66e-06	0.000282	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—osteoporosis	5.6e-06	0.000279	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ENO1—osteoporosis	5.48e-06	0.000273	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMA5—osteoporosis	5.4e-06	0.000269	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMA2—osteoporosis	5.4e-06	0.000269	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—osteoporosis	5.34e-06	0.000266	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—osteoporosis	5.21e-06	0.00026	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—osteoporosis	5.19e-06	0.000259	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—osteoporosis	4.46e-06	0.000223	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—osteoporosis	4.4e-06	0.000219	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—osteoporosis	4.39e-06	0.000219	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.38e-06	0.000218	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—osteoporosis	4.27e-06	0.000213	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—osteoporosis	3.91e-06	0.000195	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADCY5—osteoporosis	3.58e-06	0.000178	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX1—osteoporosis	3.56e-06	0.000178	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—osteoporosis	3.31e-06	0.000165	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—osteoporosis	3.29e-06	0.000164	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—osteoporosis	2.63e-06	0.000131	CbGpPWpGaD
